Biggest News Aggregation in the World

Ellipsoid Zone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ellipsoid Zone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ellipsoid Zone Today - Breaking & Trending Today

Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022 - Belite Bio (NASDAQ:BLTE) - Press Release

Published: October 2, 2022

LBS-008 (aka Tinlarebant) was safe and well tolerated in adolescent Stargardt Disease (STGD1) subjects at 12-month time pointThe majority of the subje

Source: wiredprnews.com

Belite Bio Presented 12-Month Interim Results of LBS-008

Published: October 2, 2022

LBS-008 (aka Tinlarebant) was safe and well tolerated in adolescent Stargardt Disease (STGD1) subjects at 12-month time pointThe majority of the subjects...

Source: globenewswire.com

Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022

Published: October 2, 2022

02.10.2022 - LBS-008 (aka Tinlarebant) was safe and well tolerated in adolescent Stargardt Disease (STGD1) subjects at 12-month time pointThe majority of the subjects showed stabilization of BCVA in at least one eyeA trend for preventing or slowing expansion of ... Seite 1

Source: wallstreet-online.de

Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022

Published: May 5, 2022

LBS-008 showed an acceptable safety profile in adolescent Stargardt disease subjectsA trend for stabilized or improved visual acuity was observedObserved adverse events were anticipated based on the... | May 5, 2022

Source: marketscreener.com